Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review

Vascular health and risk management

Volumn 10, Issue , 2014, Pages 627-639

  Gómez Outes, Antonio ^a   Suárez Gea, M Luisa ^a   Lecumberri, Ramón ^a   Terleira Fernández, Ana I sabel ^a   Vargas Castrillón, Emilio ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

anticoagulant; apixaban; dabigatran; edoxaban; pulmonary embolism; rivaroxaban

Indexed keywords

ANTICOAGULANT AGENT;

BLEEDING; BLOOD; CHEMICALLY INDUCED; CHI SQUARE DISTRIBUTION; EVIDENCE BASED MEDICINE; HUMAN; META ANALYSIS; MORTALITY; ODDS RATIO; ORAL DRUG ADMINISTRATION; PULMONARY EMBOLISM; RECURRENT DISEASE; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

ADMINISTRATION, ORAL; ANTICOAGULANTS; CHI-SQUARE DISTRIBUTION; EVIDENCE-BASED MEDICINE; HEMORRHAGE; HUMANS; ODDS RATIO; PULMONARY EMBOLISM; RECURRENCE; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 84996497401     PISSN: None     EISSN: 11782048     Source Type: Journal    
DOI: 10.2147/VHRM.S50543     Document Type: Article

References (0)